Skip to main content
Premium Trial:

Request an Annual Quote

Addtech Acquires Reagent, Instrument Firm BioNordika

NEW YORK (GenomeWeb News) – Swedish firm Addtech Life Science today announced it has acquired BioNordika Holding.

Addtech Life Science is a business area in the Addtech Group. BioNordika Holding is the parent company of the BioNordika Group, which markets reagents and instruments for biomedical research, primarily to the pharmaceutical industry and public institutions.

BioNordika Group has subsidiaries in Denmark, Estonia, Finland, Norway, and Sweden. It has 24 employees and SEK80 million ($11.8 million) in sales.

The purchase is expected to be complementary to Addtech Life Science's Diagnostic Business Unit, which sells reagents and equipment to healthcare laboratories in the Nordic region.

The deal, which closes today, is anticipated to be "marginally" accretive to Addtech Life Science's earnings per share in the current year, it said.

Terms of the acquisition were not disclosed.

The Scan

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.